Healthcare -
Biotechnology - NASDAQ - US
$ 18.96
1.44 %
$ 3.15 B
Market Cap
24.31
P/E
ACAD - STOCK-BASED COMPENSATION
Stock-based Compensation ACAD - ACADIA Pharmaceuticals Inc.
66.4 M
LAST VALUE
2.18%
2 YEAR CAGR
-4.02%
5 YEAR CAGR
27.81%
10 YEAR CAGR